Medicine and Dentistry
Diseases
100%
Systematic Review
89%
Surgery
80%
Meta-Analysis
76%
Apoplexy
75%
Magnetic Resonance Imaging
73%
Mechanical Thrombectomy
68%
Quality of Life
64%
Neoplasm
63%
Overall Survival
63%
Epileptic Seizure
61%
Diagnosis
56%
Biological Marker
55%
Drug Therapy
52%
Aneurysm
52%
Adverse Event
52%
Infection
50%
COVID-19
48%
Brain Ischemia
47%
Epidermolysis bullosa
46%
Cohort Analysis
46%
Odds Ratio
46%
Heart Rehabilitation
45%
Prostate Cancer
43%
Breast Cancer
40%
Computer Assisted Tomography
39%
Adolescence
39%
Comorbidity
39%
Pediatrics
38%
Status Epilepticus
37%
Cardiovascular Disease
37%
Prevalence
36%
Randomized Controlled Trial
34%
Congestive Heart Failure
34%
Hazard Ratio
32%
Rectum Cancer
31%
Melanoma
30%
Injury
30%
Neck
30%
Malignant Neoplasm
30%
Health Care Cost
29%
Surgeon
29%
Intracranial Aneurysm
28%
Partial Seizure
28%
Recurrent Disease
28%
Aortic Valve Stenosis
28%
Percutaneous Aortic Valve Replacement
27%
Epilepsy Surgery
27%
Severe Acute Respiratory Syndrome Coronavirus 2
26%
Exercise
26%
Cardiology
26%
Secondary Prevention
26%
Cardiovascular System
25%
Body Mass Index
25%
Clinical Trial
25%
Cerebral Hemorrhage
25%
Retrospective Study
24%
Progression Free Survival
24%
Physical Activity
24%
Cross Sectional Study
23%
Pulmonary Hypertension
23%
Outpatient
23%
Modified Rankin Scale
23%
Retrospective Cohort Study
23%
Atrial Fibrillation
23%
Middle Cerebral Artery Occlusion
22%
Prematurity
22%
Transplantation
22%
Systemic Therapy
21%
Bleeding
21%
Internal Fixation
21%
Mortality Rate
21%
Colorectal Carcinoma
20%
Middle Cerebral Artery
20%
Positron Emission Tomography-Computed Tomography
20%
Radiation Therapy
20%
Ovarian Cancer
20%
Cancer Surgery
20%
Chemotherapy
20%
Propensity Score Matching
20%
Clinician
20%
Lung
19%
Pelvis
19%
Oxidative Stress
18%
Arm
18%
Frailty
18%
Analgesia
18%
Primary Prevention
17%
Clear Cell Renal Cell Carcinoma
17%
Geriatrics
17%
Drug Resistant Epilepsy
17%
Chemoradiotherapy
17%
Diagnostic Performance
17%
Positron Emission Tomography
17%
Spinal Cord Injury
17%
Observational Study
17%
Percutaneous Thrombectomy
17%
Free Tissue Graft
17%
Diverticulum
17%
Disease Course
16%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
97%
Adverse Event
50%
Biological Marker
49%
Overall Survival
48%
Cohort Study
40%
Epidermolysis bullosa
36%
Prostate Cancer
34%
Congestive Heart Failure
33%
Cerebrovascular Accident
32%
Clinical Trial
31%
Breast Cancer
30%
Chemotherapy
30%
Malignant Neoplasm
29%
Neoplasm
29%
Infection
27%
Pulmonary Hypertension
25%
Inflammation
24%
Cardiovascular Disease
24%
SARS Coronavirus
23%
Randomized Controlled Trial
23%
Epileptic State
22%
Syndrome
22%
Injury
22%
Observational Study
22%
Prevalence
20%
Comorbidity
20%
Progression Free Survival
19%
Recurrent Disease
19%
Placebo
19%
Focal Epilepsy
17%
Aortic Valve Stenosis
17%
Coronary Artery Disease
17%
Polyethylene Terephthalate
16%
Non Insulin Dependent Diabetes Mellitus
16%
Acute Myeloid Leukemia
16%
Hospital Mortality
16%
Childhood Obesity
16%
Pharmacotherapy
16%
Nonalcoholic Fatty Liver
16%
Melanoma
16%
Heart Infarction
16%
Squamous Cell Carcinoma
15%
Olaparib
15%
Global Disease Burden
15%
Chronic Kidney Failure
15%
Empagliflozin
15%
Lutetium 177
15%
Disease Course
14%
Mortality Rate
14%
Liver Disease
14%
Brain Ischemia
14%
Remdesivir
13%
Fatty Liver
13%
Bleeding
13%
Brain Hemorrhage
13%
Survival Rate
13%
Castration Resistant Prostate Cancer
12%
Infarction
12%
Coronavirinae
12%
Remission
12%
Sodium Glucose Cotransporter 2 Inhibitor
12%
Rankin Scale
12%
Liver Fibrosis
11%
Anemia
11%
Prospective Cohort Study
11%
Pharmacokinetics
11%
Tolerability
11%
Retrospective Study
11%
Inflammatory Bowel Disease
11%
Gallium 68
11%
Irisin
11%
Side Effect
10%
Frailty
10%
Epidermolysis Bullosa Dystrophica
10%
Sudden Cardiac Death
10%
Pembrolizumab
10%
Aneurysm
10%
Glycogen Storage Disease
10%
Prostate Specific Membrane Antigen
10%
Cyclooxygenase 2
10%
Bovine Serum Albumin
10%
Ferroptosis
10%
Hydrogen Sulfide
10%
Ovary Cancer
10%
Bevacizumab
10%
Spinal Cord Injury
10%
Intervertebral Disk Degeneration
10%
Persistent Atrial Fibrillation
10%
Atrial Fibrillation
10%
Exendin 4
10%
Fluorodeoxyglucose F 18
10%
Haemophilia A
10%
Cardiovascular Risk
9%
Chemoradiation Therapy
9%
Androgen Receptor
8%
Emicizumab
8%
Chronic Lymphatic Leukemia
8%
Disease Free Survival
8%
Renal Cell Carcinoma
8%
Acute Heart Infarction
8%